A new immunotherapy for a severe form of blood cancer will soon be available on the NHS, offering new hope to adults whose disease has returned or stopped responding to conventional treatment.
Mary Hardcastle at RapidAI looks at the advancements in health tech, explaining what hospitals need to do to implement Artificial Intelligence in the ER.
From Richard Branson to Stephen Covey it's a widely shared belief that people are a company's greatest asset - it is simply not possible to build a prosperous business without good people.
Olga Gómez de Miranda, Scientific researcher from TECNALIA illustrates the innovative technologies and strategies in place to improve sustainable development.
Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?
The first net zero operation has been conducted by surgeons in the NHS – with the patient safely recovering from a keyhole procedure to remove a bowel cancer.
Neil Macdonald, CEO at Thrive, explains how using the Impact Evaluation Standard to report on social value in government contracts can actually lead to far better outcomes for communities and for suppliers.
Dr Helen M Rowe at the Centre for Immunobiology at the Queen Mary University of London looks towards unlocking dark matter for the potential to boost immune responses in humans.
The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.
The government’s Roadmap to digital and data involves ambitions to transform digital public services, deliver world-class digital technology and systems, and attract digital talent.
Y-h. Taguchi, a professor at Chuo University, looks toward a COVID-19 infection model which uses human patients blood who have been infected by COVID-19.
